Why do medicines run out?

Graphic for article: 'Why do medicines run out?' with two circular headshots (Ross Maclagan and Amanda Cole) on a purple background.

Drug shortages are no longer rare, isolated events.

Grace Hampson is joined by Ross Maclagan, Head of Supply and Distribution Policy at the ABPI, and Amanda Cole, Director at the Office of Health Economics, to explore why shortages happen, what they cost patients and health systems, and how to build resilience into medicines supply.

They’ll discuss: 

  • Why shortages are so difficult to define and measure
  • How price erosion in off-patent markets can contribute to supply risk
  • The trade-off between low prices and supply resilience, and whether some level of shortage is ever efficient
  • The role of international cooperation, forecasting and regulatory flexibility in preventing shortages

A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud, debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.

Speakers

Listen to the episode

Never miss an episode

You may also be interested in